dalfampridine
Showing 1 - 10 of 10
Motor Neuron Disease, Upper Trial in Gainesville, Boston, New York (dalfampridine)
Active, not recruiting
- Motor Neuron Disease, Upper
- dalfampridine
-
Gainesville, Florida
- +2 more
Mar 29, 2022
Spinal Cord Injury Trial in Chicago (drug, other, behavioral)
Recruiting
- Spinal Cord Injury
- Dalfampridine
- +3 more
-
Chicago, IllinoisShirley Ryan Abilitylab
Jul 6, 2022
Multiple Sclerosis Trial in Buffalo (dalfampridine, )
Completed
- Multiple Sclerosis
- dalfampridine
- placebo
-
Buffalo, New YorkBuffalo General Hospital
Sep 29, 2020
Multiple Sclerosis, Internuclear Ophthalmoplegia, Fatigue Trial in Cleveland (Dalfampridine, Placebo)
Completed
- Multiple Sclerosis
- +2 more
- Dalfampridine
- Placebo
-
Cleveland, OhioLouis Stokes VA Medical Center, Cleveland, OH
Sep 1, 2020
Transverse Myelitis, Neuromyelitis Optica, Idiopathic Transverse Myelitis Trial in Baltimore (Dalfampridine, Placebo)
Completed
- Transverse Myelitis
- +3 more
- Dalfampridine
- Placebo
-
Baltimore, MarylandJohns Hopkins University
Mar 14, 2018
Spinal Cord Injury Trial in West Orange (Dalfampridine, Placebo)
Completed
- Spinal Cord Injury
- Dalfampridine
- Placebo
-
West Orange, New JerseyKessler Institute for Rehabilitation
Nov 29, 2017
Sleep Apnea, Obstructive Trial in Boston (Placebo, Dalfampridine)
Completed
- Sleep Apnea, Obstructive
- Placebo
- Dalfampridine
-
Boston, MassachusettsSleep Disorders Research Program Brigham and Women's Hospital
Jul 14, 2017
Non Arteritic Ischemic Optic Neuropathy Trial in Philadelphia (dalfampridine, Placebo)
Completed
- Non Arteritic Ischemic Optic Neuropathy
- dalfampridine
- Placebo
-
Philadelphia, PennsylvaniaNeuro-Ophthalmologic Associates, PC
Jan 22, 2016
Spinocerebellar Ataxias Type 1, Spinocerebellar Ataxias Type 2, Spinocerebellar Ataxias Type 3 Trial in Gainesville
Completed
- Spinocerebellar Ataxias Type 1
- +3 more
- Dalfampridine
- Placebo
-
Gainesville, FloridaUniversity of Florida
Jan 8, 2015
Multiple Sclerosis, Fatigue Trial in Portland (Dalfampridine, Placebo)
Completed
- Multiple Sclerosis
- Fatigue
- Dalfampridine
- Placebo
-
Portland, OregonOregon Health and Science University
May 16, 2014